This scoring system indicates that levels of AMBRA1 were greater (score 4–5) in tumors with a higher prostate cancer grading system (Fig. 2a, left panel), again suggesting a positive correlation between AMBRA1 positivity and PCa lesions. This evidence concerns the gene AMBRA1 and Familial prostate cancer.